Impact of Art Therapy on Anxiety Identified During Hospitalizations Among Children With Cystic Fibrosis Aged 8 to 13
Overview
Currently the management of cystic fibrosis (CF) patients is mainly based on symptomatic treatments. The arrival of children in day hospital, every 2 to 3 months, is for many of them and those around them, stressful, rarely expressed, but noticeable by the care team. In line with the recommendations of the High Authority of Health, the multidisciplinary team of Resources and Skills Centre for Cystic Fibrosis (CRCM) Pediatric of Nantes University Hospital offers a therapeutic education program tailored to the needs of children with cystic fibrosis and their families . The aim is to support children and parents in the acquisition of self-care skills (knowledge and skills) and coping skills, such as managing stress and emotions . Our goal is to demonstrate that art therapy, mobilizing coping skills of the child, facilitates its expressive capabilities and reduces anxiety.
Full Title of Study: “Impact of Art Therapy on Anxiety Identified During the Quarterly Update of Hospitalizations Among Children With Cystic Fibrosis Aged 8 to 13 – Pilot Study”
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Prospective
- Study Primary Completion Date: November 27, 2018
Interventions
- Other: Non interventional Study
- Parents and children will be informed at the inclusion visit (V0) that is a normal consultation under the care of the child. The children included will be followed for 18 months with a maximum of 6 months without meeting art therapy sessions and 12 months with art therapy. The art therapy sessions will be scheduled during the usual consultations conducted as part of the care of children. At each visit, clinical, paraclinical and external factors of anxiety will be collected and anxiety of parents and children will be measured using specific questionnaires.
Clinical Trial Outcome Measures
Primary Measures
- Changes in the overall score of children’s anxiety after 4 visits including art therapy sessions compared to basal mean level of the first two visits without art therapy.
- Time Frame: Up to 18 months
Participating in This Clinical Trial
Inclusion Criteria
- Children with CF aged 8 to 13 years as part of their monitoring at CRCM children of Nantes University Hospital – Parents and children willing to participate in research Non inclusion Criteria:
- Emergency consultation – Planned move
Gender Eligibility: All
Minimum Age: 8 Years
Maximum Age: 13 Years
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Nantes University Hospital
- Provider of Information About this Clinical Study
- Sponsor
- Overall Official(s)
- Valérie DAVID, Dr, Principal Investigator, Nantes University Hospital
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.